ESMO FAMILY SITES
ESMO 2012 PROGRAM
CORRIGENDUM: Due to a printing error in the Advanced Program brochure, please note that the YO sessions are correct in the ONLINE searchable program and PDF.
CME accreditation
The program of this event will be:
- Submitted for ESMO-MORA category 1 points;
- Submitted for CME accreditation to ACOE (Accreditation Council for Oncology in Europe). ACOE Accreditation has been endorsed by the Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). These credits are also recognized by the American Medical Association (AMA) as Physician’s Recognition Award (AMA PRA Category 1 credits).
Congress Webcast
The entire program of ESMO 2012 Congress will be Webcast. Access to the Congress Webcast will be granted to all ESMO members through OncologyPRO. It will also be available on the ESMO website for the first 6 months following the Congress to all Congress delegates who elect to pay the additional webcast fee. After this period the webcast will be removed from the ESMO website.
Publications
Articles relating to the Educational and Challenge Your Expert sessions will be published in the Educational Book (CD-Rom only) as a supplement of the official ESMO scientific journal,Annals of Oncology. All invited and accepted abstracts will be published in the Abstract Book (online and USB only), also a supplement of Annals of Oncology.
OncologyPRO
Access to the highest quality scientific knowledge at a click. In addition to a wider range of scientific information and news services, OncologyPRO provides access to materials developed by ESMO. Webcasts and reports from the Vienna Congress will be available on http://oncologypro.esmo.org/ ESMO designed OncologyPRO in partnership with Thomson Reuters specifically to foster the sharing of knowledge and best practice for both clinical practice and research. OncologyPRO offers ESMO members an unparalleled resource – integrating
regularly updated oncology news, clinical research, biomarker and drug databases, practice guidelines and tools, clinical trial information, abstracts from more than 110 oncology-relevant journals and more, in a simple, searchable platform.
BACK TO TOP
PRINT THIS PAGE